| Telaprevir for retreatment of HCV infection S Zeuzem, P Andreone, S Pol, E Lawitz, M Diago, S Roberts, R Focaccia, ... New England Journal of Medicine 364 (25), 2417-2428, 2011 | 2112 | 2011 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2071 | 2017 |
| Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study J Lammer, K Malagari, T Vogl, F Pilleul, A Denys, A Watkinson, M Pitton, ... Cardiovascular and interventional radiology 33, 41-52, 2010 | 1789 | 2010 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1489 | 2018 |
| Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ... Gastroenterology 138 (4), 1338-1345. e7, 2010 | 1461 | 2010 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1043 | 2019 |
| Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: the RELIEF trial R Bañares, F Nevens, FS Larsen, R Jalan, A Albillos, M Dollinger, ... Hepatology 57 (3), 1153-1162, 2013 | 633 | 2013 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 558 | 2014 |
| ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype … P Andreone, MG Colombo, JV Enejosa, I Koksal, P Ferenci, A Maieron, ... Gastroenterology 147 (2), 359-365. e1, 2014 | 545 | 2014 |
| The natural history of pain in alcoholic chronic pancreatitis RW Ammann, B Muellhaupt, Zurich Pancreatitis Study Group Gastroenterology 116 (5), 1132-1140, 1999 | 534 | 1999 |
| Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 … M Manns, D Samuel, EJ Gane, D Mutimer, G McCaughan, M Buti, ... The Lancet Infectious Diseases 16 (6), 685-697, 2016 | 512 | 2016 |
| Cigarette smoking accelerates progression of alcoholic chronic pancreatitis P Maisonneuve, AB Lowenfels, B Müllhaupt, G Cavallini, PG Lankisch, ... Gut 54 (4), 510-514, 2005 | 470 | 2005 |
| The echinococcoses: diagnosis, clinical management and burden of disease P Kern, AM Da Silva, O Akhan, B Müllhaupt, KA Vizcaychipi, C Budke, ... Advances in parasitology 96, 259-369, 2017 | 461 | 2017 |
| Are there better guidelines for allocation in liver transplantation?: A novel score targeting justice and utility in the model for end-stage liver disease era P Dutkowski, CE Oberkofler, K Slankamenac, MA Puhan, E Schadde, ... Annals of surgery 254 (5), 745-754, 2011 | 442 | 2011 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 411 | 2014 |
| Human alveolar echinococcosis after fox population increase, Switzerland A Schweiger, RW Ammann, D Candinas, PA Clavien, J Eckert, B Gottstein, ... Emerging infectious diseases 13 (6), 878, 2007 | 379 | 2007 |
| HOPE for human liver grafts obtained from donors after cardiac death P Dutkowski, A Schlegel, M de Oliveira, B Müllhaupt, F Neff, PA Clavien Journal of hepatology 60 (4), 765-772, 2014 | 364 | 2014 |
| Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C PY Bochud, T Cai, K Overbeck, M Bochud, JF Dufour, B Müllhaupt, ... Journal of hepatology 51 (4), 655-666, 2009 | 357 | 2009 |
| Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease A Mikocka-Walus, V Pittet, JB Rossel, R von Känel, C Anderegg, ... Clinical Gastroenterology and Hepatology 14 (6), 829-835. e1, 2016 | 326 | 2016 |
| Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate … JA Bachofner, PV Valli, A Kröger, I Bergamin, P Künzler, A Baserga, ... Liver International 37 (3), 369-376, 2017 | 307 | 2017 |
